313 related articles for article (PubMed ID: 21636256)
1. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
DelDot ME; Lipman J; Tett SE
Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
4. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
8. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
Fish DN; Teitelbaum I; Abraham E
Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
[TBL] [Abstract][Full Text] [Related]
11. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin clearance in high-volume venovenous hemofiltration.
Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS
Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
[TBL] [Abstract][Full Text] [Related]
18. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
[TBL] [Abstract][Full Text] [Related]
19. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
Gattringer R; Meyer B; Heinz G; Guttmann C; Zeitlinger M; Joukhadar C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2006 Aug; 58(2):367-71. PubMed ID: 16782745
[TBL] [Abstract][Full Text] [Related]
20. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
